Loading memory…
Loading memory…
Patent portfolio assigned to Phenomic (verified via public assignee records). Phenomic AI, Toronto/Boston biotech (scTx single-cell platform targeting tumor stroma). Pharma collaborations with Boehringer Ingelheim and Astellas/Xyphos. Patent WO2022241297A2 lists Phenomic AI Inc as assignee; exact total count not enumerated.